BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,291,000 | -51.8% | 130,900 | -6.4% | 2.10% | -51.2% |
| Q4 2021 | $19,282,000 | -21.3% | 139,900 | -20.7% | 4.30% | -27.3% |
| Q3 2021 | $24,490,000 | +43.1% | 176,400 | 0.0% | 5.91% | +30.7% |
| Q2 2021 | $17,113,000 | +41.9% | 176,400 | 0.0% | 4.52% | +41.7% |
| Q1 2021 | $12,057,000 | -29.8% | 176,400 | -12.0% | 3.19% | -32.0% |
| Q4 2020 | $17,178,000 | +92.3% | 200,400 | +45.9% | 4.69% | +62.7% |
| Q3 2020 | $8,931,000 | +186.3% | 137,400 | +205.3% | 2.88% | +178.0% |
| Q2 2020 | $3,119,000 | +39.8% | 45,000 | -11.7% | 1.04% | +25.4% |
| Q2 2019 | $2,231,000 | +44.5% | 50,949 | +69.8% | 0.83% | +45.1% |
| Q1 2019 | $1,544,000 | – | 30,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |